Show Summary Details
Page of

Crossover Trials 

Crossover Trials
Study Design and Statistics

Margaret A. Winker

and Stephen J. Lurie

Page of

PRINTED FROM AMA MANUAL OF STYLE ONLINE ( © American Medical Association, 2009. All Rights Reserved. Under the terms of the license agreement, an individual user may print out a PDF of a single chapter of a title in AMA Manual of Style Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 January 2020

In a crossover trial, participants receive more than 1 of the treatments under investigation, usually in a randomly determined sequence, and with a prespecified amount of time (a ) between sequential treatments. The participants and the investigators are generally to the treatment assignment (double-blinded). This experimental design is often used for evaluating drug treatments. Each participant serves as his or her own control, thereby eliminating variability when comparing treatment effects and reducing the sample size needed to detect a effect. Most considerations of parallel-design randomized trials apply. Rather than indicating which participants were assigned to which condition, the CONSORT flow

Access to the complete content on AMA Manual of Style requires a subscription or purchase. Public users are able to search the site without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.